Overview A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge Status: Completed Trial end date: 2012-05-01 Target enrollment: Participant gender: Summary Phase 1 study to determine the effect of oral TR-701 FA on SBP response when administered with tyramine Phase: Phase 1 Details Lead Sponsor: Trius Therapeutics LLCTreatments: TedizolidTedizolid phosphateTorezolid phosphateTyramine